Study of the Effectiveness and Safety of Botulinum Toxin Type- A for Treatment of Androgenetic Alopecia in men | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 179, Volume 90, Issue 2, January 2023, Pages 3162-3166 PDF (426.19 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2023.290615 | ||
| Authors | ||
| Emad El-din Abdelmonaem El-Gamal; Ramadan Mohamed El Dahshan; Nehal Gamil Hassan Hafez* | ||
| Abstract | ||
| Background: Up to 80% of men and 50% of women have androgenetic alopecia (AGA), a non-scarring hair loss condition that is marked by a gradual shrinkage of the hair follicle, throughout adolescence and beyond puberty, Aim and objectives: This study aimed to assess the efficiency and security of using type A botulinum toxin (BTA) to treat androgenetic alopecia in males, Subjects and methods: This interventional research was conducted in Dermatology, Venereology and Andrology Department Outpatient Clinic, Al-Azhar University Hospital (Damietta) and Mubarak Hospital in Giza (Ministry of Heath). This study included 20 patients with androgenetic alopecia grade II-IV according to Norwood Hamilton criteria, Result: There was statistically significant decrease of vellous hair count between first session 48.6 to 39.7 second session and 31.25 at third session with percent of change is the highest between 1st and 3rd session (35.7%) then between second and third session (21.3%) and the lowest percent of change was detected between 1st session and 2nd session (18.3%).There was statistically significant increase of mean hair thickness between first & second session 56.30 & 66.20 and 78.2 at third session with percent of change is the highest between 1st and 3rd session (38.9%), then second and third session (18.1%) and between 1st session and 2nd session (17.6%), Conclusion: The results of the current research showed that BTA is a safe and successful treatment for AGA and has outstanding outcomes. These findings provide an innovative theoretical framework and therapeutic approach for the management of AGA, | ||
| Keywords | ||
| Androgenetic alopecia (AGA) | ||
|
Statistics Article View: 273 PDF Download: 628 |
||
